myelopeptides

RN refers to myelopeptide 1; immune system peptides from bone marrow; act as analgesics and immunoregulators; MP-1 to MP-4 have been sequenced

Also Known As:

MP-1 peptide; MP-2 peptide; MP-3 peptide; myelopeptide (SAP); myelopeptide 1; myelopeptide 2; myelopeptide 3; myelopid

Networked: 36 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - myelopeptides: 36

Experts

1.	Starostina, M V: 2 articles (09/2021 - 05/2015)
2.	Berkasova, N L: 2 articles (03/2008 - 01/2007)
3.	Chereshnev, V A: 2 articles (03/2008 - 01/2007)
4.	Chereshneva, M V: 2 articles (03/2008 - 01/2007)
5.	Gavrilova, T V: 2 articles (03/2008 - 01/2007)
6.	Aleksander, S K: 2 articles (11/2007 - 03/2004)
7.	Fonina, L A: 2 articles (11/2007 - 03/2004)
8.	Iuminova, N V: 2 articles (11/2007 - 03/2004)
9.	Liashenko, V A: 2 articles (11/2007 - 03/2004)
10.	Mikhaĭlova, A A: 2 articles (11/2007 - 03/2004)

Related Diseases

1.	Neuroblastoma 05/01/2015 - "[Protective Effects of Myelopeptides in Neuroblastoma C-1300 Cell Culture]." 05/01/2015 - "The effects of bone marrow regulatory peptides--myelopeptides 1-6--in mouse neuroblastoma C-1300 were studied. " 05/01/2015 - "Neuroprotective abilities of myelopeptides were shown on the models of morphine toxity and oxygen-glucose deprivation in neuroblastoma cell culture."
2.	Infections 09/01/2000 - "[Protective efficacy of combined administration of the multicomponent vaccine and the immunomodulator myelopid in experimental infections in mice]." 09/01/2000 - "The influence of myelopid (MP) on the protective activity of polycomponent vaccine VP-4 prepared from the antigens of opportunistic bacteria was studied on experimental infections of mice, caused by Klebsiella pneumoniae, Salmonella typhimurium and Staphylococcus aureus. "
3.	Herpesviridae Infections (Herpesvirus Infection) 11/01/1996 - "[Efficacy of herpetic vaccine, larifan, myelopid and their combinations during herpesvirus infection in irradiated animals]."
4.	Measles 11/01/2007 - "[Enhancement of measles-mumps divaccine using myelopeptide 2 in experiment]." 03/01/2004 - "A model is suggested to study the effects the myelopeptide 2 (MP2) immunomodulator on the results of live measles rash immunized by vaccine. "
5.	Leukemia 09/01/2002 - "Multiple anchoring of myelopeptides on sequential oligopeptide carriers (SOC(n)): synthesis, conformation and studies in human leukemia cells." 09/01/2002 - "Myelopeptides, MP-6 (Val-Asp-Pro-Pro) and MP-4 (Phe-Arg-Pro-Arg-Ile-Met-Thr-Pro), induce metabolic changes in human leukemia cells, HL-60, characteristic of the differentiation process, which should be regarded as a promising therapeutic approach in cancer and related diseases. "

Related Drugs and Biologics

1.	Vaccines
2.	Immunologic Factors (Immunomodulators)
3.	larifan
4.	Oligopeptides
5.	Peptides (Polypeptides)
6.	Naloxone (Narcan)
7.	Morphine (MS Contin)
8.	Antigens
9.	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)
10.	Toxoids

Related Therapies and Procedures

1.	Therapeutics
2.	Intralymphatic Injections
3.	Injections
4.	Immunotherapy
5.	Aftercare (After-Treatment)